Adjuvant composition comprising FHA protein or fragment of FHA protein in free form

Details for Australian Patent Application No. 2001267613 (hide)

Owner Institut Pasteur De Lille Institut National de la Sante et de la Recherche Medicale

Inventors Riveau, Gilles; Menozzi, Franco; Capron, Andre; Poulain-Godefroy, Odile; Locht, Camille

Agent Cullen & Co

Pub. Number AU-B-2001267613

PCT Pub. Number WO01/93906

Priority 00 07302 07.06.00 FR

Filing date 7 June 2001

Wipo publication date 17 December 2001

Acceptance publication date 3 August 2006

International Classifications

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 39/10 (2006.01) Medicinal preparations containing antigens or antibodies - Brucella

C07K 14/235 (2006.01) Peptides having more than 20 amino acids

Event Publications

3 August 2006 Application Accepted

  Published as AU-B-2001267613

30 November 2006 Standard Patent Sealed

8 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001267614

2001267612